ARWA LLC’s Amgen AMGN Stock Holding History

ARWA LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.64M	Sell	4,423 -759	-15%	-$260K	0.68%	33
2026 Q1	$1.84M	Sell	5,182 -808	-13%	-$288K	0.91%	23
2025 Q4	$1.96M	Buy	+5,990	New	+$1.9M	1.14%	17

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

ARWA LLC's AMGN Position: Q2 2026 in Review

ARWA LLC reduced its Amgen (AMGN) stake by 15% in Q2 2026, selling an estimated $260K and leaving 4,423 shares worth $1.64M. The position accounts for 0.68% of the portfolio, ranked #33.

ARWA LLC first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.96M in Q4 2025. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

ARWA LLC held 4,423 shares of Amgen worth $1.64M as of Q2 2026.
ARWA LLC sold 759 Amgen shares in Q2 2026, an estimated $260K.
Amgen made up 0.68% of ARWA LLC's portfolio in Q2 2026, its #33 holding.
ARWA LLC first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
ARWA LLC's Amgen position peaked at $1.96M in Q4 2025.
3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on ARWA LLC's 13F filing for Q2 2026, filed 24 Jul 2026.